News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Whoa. Agios Pharmaceuticals (AGIO)'s Experimental Cancer Drug Makes Cancer Undetectable In Three Patients


4/7/2014 7:31:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Agios, a biotechnology company based in Cambridge, Mass., has seemed in some ways a sign of the overexcitement of the recent biotech boom. After all, the company, despite an experienced management team, a July public stock offering that raised more than $100 million, and great scientific ideas, hasn’t been able to show a single result from testing its drugs in humans.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes
Read at Reuters
Read at News-Medical
Read at The Street.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES